MOH (Molina Healthcare, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by MOH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | LEO P GROHOWSKI | Director | A | — | — |
| 2026-07-02 | Jeff D. Barlow | Chief Legal Officer | A | — | — |
| 2026-07-02 | JAMES WOYS | Chief Operating Officer | A | — | — |
| 2026-07-02 | RONNA ROMNEY | Director | A | — | — |
| 2026-07-02 | STEVEN J ORLANDO | Director | A | — | — |
| 2026-07-02 | BARBARA L BRASIER | Director | A | — | — |
| 2026-07-02 | Richard M Schapiro | Director | A | — | — |
| 2026-07-02 | RICHARD C ZORETIC | Director | A | — | — |
| 2026-07-02 | DALE B WOLF | Director | A | — | — |
| 2026-07-02 | Debra Bacon | EVP, Medicaid | MIXED | — | — |
| 2026-07-02 | Stephen H Lockhart | Director | A | — | — |
| 2026-07-02 | FRANCIS S SOISTMAN JR | Director | A | — | — |
| 2026-05-15 | MAURICE HEBERT | Chief Accounting Officer | Sell | — | — |
| 2026-05-13 | Jeff D. Barlow | Chief Legal Officer | Sell | — | — |
| 2026-05-08 | FRANCIS S SOISTMAN JR | Director | A | — | — |
| 2026-04-02 | RONNA ROMNEY | Director | A | — | — |
| 2026-04-02 | BARBARA L BRASIER | Director | A | — | — |
| 2026-04-02 | Richard M Schapiro | Director | A | — | — |
| 2026-04-02 | RICHARD C ZORETIC | Director | A | — | — |
| 2026-04-02 | DALE B WOLF | Director | A | — | — |
| 2026-04-02 | STEVEN J ORLANDO | Director | A | — | — |
| 2026-04-02 | Stephen H Lockhart | Director | A | — | — |
| 2026-04-02 | LEO P GROHOWSKI | Director | A | — | — |
| 2026-03-13 | RONNA ROMNEY | Director | Sell | — | — |
| 2026-03-02 | Debra Bacon | EVP, Medicaid | MIXED | — | — |
| 2026-03-02 | Jeff D. Barlow | Chief Legal Officer | MIXED | — | — |
| 2026-03-02 | MAURICE HEBERT | Chief Accounting Officer | MIXED | — | — |
| 2026-03-02 | JAMES WOYS | Chief Operating Officer | MIXED | — | — |
| 2026-03-02 | Mark Lowell Keim | Chief Financial Officer | MIXED | — | — |
| 2026-03-02 | Joseph M Zubretsky | President & CEO | MIXED | — | — |
| 2026-02-12 | RICHARD C ZORETIC | Director | Buy | — | — |
| 2026-01-02 | Debra Bacon | EVP, Medicaid | A | — | — |
| 2026-01-02 | BARBARA L BRASIER | Director | A | — | — |
| 2026-01-02 | DALE B WOLF | Director | A | — | — |
| 2026-01-02 | LEO P GROHOWSKI | Director | A | — | — |
| 2026-01-02 | RICHARD C ZORETIC | Director | A | — | — |
| 2026-01-02 | Richard M Schapiro | Director | A | — | — |
| 2026-01-02 | RONNA ROMNEY | Director | A | — | — |
| 2026-01-02 | Stephen H Lockhart | Director | A | — | — |
| 2026-01-02 | STEVEN J ORLANDO | Director | A | — | — |
| 2025-11-24 | Richard M Schapiro | Director | Sell | — | — |
| 2025-10-02 | BARBARA L BRASIER | Director | A | — | — |
| 2025-10-02 | LEO P GROHOWSKI | Director | A | — | — |
| 2025-10-02 | Stephen H Lockhart | Director | A | — | — |
| 2025-10-02 | STEVEN J ORLANDO | Director | A | — | — |
| 2025-10-02 | RONNA ROMNEY | Director | A | — | — |
| 2025-10-02 | Richard M Schapiro | Director | A | — | — |
| 2025-10-02 | DALE B WOLF | Director | A | — | — |
| 2025-10-02 | RICHARD C ZORETIC | Director | A | — | — |
| 2025-08-08 | RONNA ROMNEY | Director | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 3,040,788 | — |
| — | Director | 2,708,273 | — |
| — | Exec. V.P., Research | 877,078 | — |
| — | — | 586,256 | — |
| — | Director | 488,937 | — |
| — | 10%+ Owner | 411,826 | — |
| — | President & CEO | 356,730 | — |
| — | 10%+ Owner | 155,787 | — |
| — | 10%+ Owner | 155,787 | — |
| — | — | 125,913 | — |
| — | Chief Operating Officer | 90,178 | — |
| — | — | 84,956 | — |
| — | Chief Financial Officer | 83,251 | — |
| — | Exec. VP, General Counsel | 76,509 | — |
| — | Chief Legal Officer | 67,313 | — |
| — | Former Chief Financial Officer | 52,707 | — |
| — | Chief Medical Officer | 51,122 | — |
| — | Director | 47,537 | — |
| — | — | 47,415 | — |
| — | Director | 45,750 | — |
| — | Director | 44,078 | — |
| — | EVP, Health Plans | 37,093 | — |
| — | Director | 31,342 | — |
| — | Chief Financial Officer | 31,020 | — |
| — | Chief Medical Officer | 29,441 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MOH quote page; the site-wide leaderboard is on the insider transactions hub.